|
FHTX Foghorn Therapeutics Inc 1822462 |
| Balance Sheet |
|
Current Assets
|
$188,064,000.00 |
|
Assets
|
$222,167,000.00 |
|
Current Liabilities
|
$64,404,000.00 |
|
Liabilities
|
$298,575,000.00 |
|
Equity
|
$-76,408,000.00 |
|
Shares Out
|
58710490.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-25,266,000.00 |
|
Investing Cash Flow
|
$-17,719,000.00 |
| Market Analysis |
Market Cap
|
$278,287,722.60 |
|
Price
|
$4.51 |
|
PB
|
1.34 |
|
EPS
|
-0.29 |
|
PS
|
23.81 |
|
FCF
|
$-25,266,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:31 |
|
| Apr |
May |
Jun |
| 2026-03-11 |
-1.18 |
|
|
2026-05-07 |
-0.29 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-05 |
-0.28 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-05 |
-0.25 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FHTX documents filed with the SEC.
FHTX Filings
Clear
